Evidence map›Paper›PMID 32826873›Full record

ArticleCell death & disease2020

Protein phosphatase 4 promotes Hedgehog signaling through dephosphorylation of Suppressor of fused.

Hengqing Liao, Jing Cai, Chen Liu, Longyan Shen, Xiaohong Pu, Yixing Yao, Bo'ang Han, Tingting Yu, Steven Y Cheng, Shen Yue

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Hedgehog pathway in sarcoma: from preclinical mechanism to clinical application.Journal of cancer research and clinical oncology · 2023
    Review
  6. Review
  7. Article
  8. From mesenchymal niches to engineeredMaterials today. Bio · 2022
    Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Hengqing Liao *Department of Medical Genetics, Nanjing Medical University, Nanjing, 211166, China.
Jing Cai *Department of Medical Genetics, Nanjing Medical University, Nanjing, 211166, China.
Chen Liu *Department of Medical Genetics, Nanjing Medical University, Nanjing, 211166, China.
Longyan ShenDepartment of Pathology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, 210037, China.
Xiaohong PuDepartments of Pathology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, China.ORCID http://orcid.org/0000-0002-8870-148X
Yixing YaoDepartment of Medical Genetics, Nanjing Medical University, Nanjing, 211166, China.
Bo'ang HanDepartment of Medical Genetics, Nanjing Medical University, Nanjing, 211166, China.
Tingting YuDepartment of Medical Genetics, Nanjing Medical University, Nanjing, 211166, China. tingting@njmu.edu.cn.
Steven Y ChengDepartment of Medical Genetics, Nanjing Medical University, Nanjing, 211166, China. sycheng@njmu.edu.cn.
Shen YueDepartment of Medical Genetics, Nanjing Medical University, Nanjing, 211166, China. yueshen@njmu.edu.cn.
Nanjing Medical University · CNNanjing University of Chinese Medicine · CNJiangsu Cancer Hospital · CNLiuzhou General Hospital · CNNanjing Drum Tower Hospital · CNSecond Affiliated Hospital of Nanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reversible phosphorylation of Suppressor of fused (Sufu) is essential for Sonic Hedgehog (Shh) signal transduction. Sufu is stabilized under dual phosphorylation of protein kinase A (PKA) and glycogen synthase kinase 3β (GSK3β). Its phosphorylation is reduced with the activation of Shh signaling. However, the phosphatase in this reversible phosphorylation has not been found. Taking advantage of a proteomic approach, we identified Protein phosphatase 4 regulatory subunit 2 (Ppp4r2), an interacting protein of Sufu. Shh signaling promotes the interaction of these two proteins in the nucleus, and Ppp4 also promotes dephosphorylation of Sufu, leading to its degradation and enhancing the Gli1 transcriptional activity. Finally, Ppp4-mediated dephosphorylation of Sufu promotes proliferation of medulloblastoma tumor cells, and expression of Ppp4 is positively correlated with up-regulation of Shh pathway target genes in the Shh-subtype medulloblastoma, underscoring the important role of this regulation in Shh signaling.

Indexed as

AnimalsCell LineCell NucleusCyclic AMP-Dependent Protein KinasesFibroblastsGlycogen Synthase Kinase 3 betaHedgehog ProteinsKruppel-Like Transcription FactorsMedulloblastomaMicePhosphoprotein PhosphatasesPhosphorylationProteomicsRepressor ProteinsSignal TransductionZinc Finger Protein GLI1Cyclic AMP-Dependent Protein KinasesGlycogen Synthase Kinase 3 betaGsk3b protein, mouseHedgehog ProteinsKruppel-Like Transcription FactorsPhosphoprotein Phosphatasesprotein phosphatase 4Repressor ProteinsSufu protein, mouseZinc Finger Protein GLI1

Identifiers

PMID32826873
PMCPMC7442787
OpenAlexW3081416103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.